This study aimed to examine the value of pre-treatment AST/ALT in the prognosis of HCC patients who received thermal ablation combined with simultaneous TACE and establish a prognosis model by developing a nomogram incorporating AST/ALT ratio into BCLC staging classification. The gene discussed is GPT; the disease is hepatocellular carcinoma.